,
your personalized virtual assistant to find clinical trials. Go head, 
Howard M. Gross, MD
CCOP - DaytonDayton, Ohio - 45420 (937-832-1093) Dayton Clinical Oncology ProgramDayton, Ohio - 45429 |
- CLINICAL TRIALS 4
- CONDITIONS6
- INTERVENTIONS18
- SINCE2006
Zoledronate Vitamin D and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer Lung Cancer or Breast Cancer
July 2006 - March 2013
Combination Chemotherapy Followed By Docetaxel or Ixabepilone in Treating Patients Who Have Undergone Surgery for Nonmetastatic Breast Cancer
September 2007 - June 2014
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative HER2-Negative Breast Cancer
May 2009 - January 2022
Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
March 2006 - June 2012
Breast Neoplasms
Lung Neoplasms
Prostatic Neoplasms
Neoplasm Metastasis
Bone Neoplasms
Bone Marrow Diseases
Zoledronic Acid
Bevacizumab
Docetaxel
Fluorouracil
Adjuvant Therapy
Cyclophosphamide
Vitamin D
Pegfilgrastim
Doxorubicin
Calcium Carbonate
Ixabepilone
Calcium Citrate
Calcium Glucarate
Calcium Gluconate
Samarium Sm 153 Lexidronam Pentasodium
Strontium Chloride Sr 89
Epirubicin Hydrochloride
Zometa® (Zoledronic Acid)
